Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

VICL:US

0.9889 USD 0.0311 3.05%

As of 15:53:32 ET on 03/02/2015.

Snapshot for Vical Inc (VICL)

Open: 1.0200 Day's Range: 0.9600 - 1.0300 Volume: 372,368
Previous Close: 1.0200 52wk Range: 0.8936 - 1.6001 1-Yr Rtn: -34.93%

Stock Chart for VICL

No chart data available.
  • VICL:US 0.9898
  • 1D
  • 1M
  • 1Y
1.0200
Interactive VICL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VICL

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1900
Est. EPS (USD) (12/2015) -0.2100
Est. PEG Ratio -
Market Cap (M USD) 91.29
Shares Outstanding (M) 90.38
30 Day Average Volume 277,103
Price/Book (mrq) 1.6025
Price/Sale (ttm) 5.7784
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VICL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VICL

Vical Incorporated develops gene-based pharmaceutical products for human therapy. The Company develops cancer product candidates, as well as develops vaccines for infectious diseases and gene-based delivery of therapeutic proteins for other disorders.

Vijay B SamantPresident/CEO/Acting CFOIgor P BilinskySenior VP:Corporate Dev
Anthony A RamosVP:Finance/Chief Acctg OfficerMammen P Mammen JrVP:Clinical Vaccines
More Company Profile & Key Executives for VICL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil